Japanese stock ADRs were dominated by buying in the US stock market on the 20th, with gains in 武田薬品工業 and ソニーグループ standing out. トヨタ自動車 also rose, while みずほフィナンシャルグループ fell.
Japanese stock American depositary receipts (ADRs) favored buying in U.S. trading on the 20th. With the Dow Jones Industrial Average rising, buying was reportedly seen spreading to Japanese stock ADRs, while the Nikkei 225 fell. The report was carried by Nikkei QUICK News (NQN). Investors consequently focused on the performance of Japanese companies in the U.S. market.
By stock, the ADRs of Takeda Pharmaceutical and Sony Group both rose. Takeda in particular reportedly attracted buying on expectations surrounding its new earnings outlook and the performance of its treatments. Sony Group may also have been supported by expectations for its earnings and the rollout of new products and services. Toyota Motor's ADR was also reported to have risen.
Meanwhile, Mizuho Financial Group's ADR fell. The report, summarized by NQN, said that among the broader market moves, financial stocks turned lower. This highlighted the divergence in the performance of individual Japanese stock ADRs in the U.S. market.